Raymond James Financial
ARMP icon

Raymond James Financial’s Armata Pharmaceuticals ARMP Stock Holding History

Raymond James Financial’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,000
Closed -$1.9K – 5064
2025
Q2 		$1.9K Buy
+1,000
New +$1.62K ﹤0.01% 6425

Other funds holding ARMP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SWM
SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return
GWM
GSB Wealth Management Guilford, Connecticut $498M AUM 27.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Raymond James Financial's ARMP Position: Q3 2025 in Review

Raymond James Financial sold out of Armata Pharmaceuticals (ARMP) in Q3 2025, closing a stake of 1,000 shares — an estimated $1.9K sold.

Raymond James Financial first reported a position in ARMP in Q2 2025 and held it in 1 quarter. The position peaked at $1.9K in Q2 2025. 28 funds tracked by Wall St. Rank hold ARMP as of Q3 2025.

  • Raymond James Financial reported no remaining Armata Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 1,000 Armata Pharmaceuticals shares in Q3 2025, an estimated $1.9K.
  • Raymond James Financial first reported a position in Armata Pharmaceuticals in Q2 2025 and held it in 1 quarter.
  • Raymond James Financial's Armata Pharmaceuticals position peaked at $1.9K in Q2 2025.
  • 28 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.